The global Medical Hyperspectral Imaging (HSI) market size was estimated to be US$ 275 million in 2021 and is expected grow at a CAGR of 6.3% between 2023 to 2032.

Medical Hyperspectral Imaging (HSI) is a diagnostic imaging technique that is highly patient-specific and non-invasive. HSI technology is increasingly used in biomedical and pharmaceutical imaging applications. Hyperspectral analysis can be done with light frequencies ranging from the ultraviolet (UV) to infrared (IR) spectrum or by use of electromagnetic radiation of lower frequencies as well. Detailed information on physiological components such as the detailed shape and structure of organs or their chemical composition can be obtained by the use of such medical hyperspectral imaging devices.

When light or electromagnetic waves pass through biological tissue, it gets differentially scattered and absorbed by various non-homogenous constituents like haemoglobin, water, cells, etc. This difference in the scattering pattern of light or radiation can be detected to observe notable changes as the disease progresses. Such use of reflected, fluorescent, or transmitted light by HSI devices has proved to be very helpful in disease prognosis and treatment strategies. Therefore, the use of hyperspectral imaging for medical purposes has ushered in a new era of non-invasive diagnosis and surgical guidance.

Uses of hyperspectral imaging devices in the medical sector:

Hyperspectral imaging techniques can offer a thorough understanding of complex medical products, including their efficacy in real-time. These results are visible with offline lab equipment as well as a variety of other tools that can meet the analytical measurement requirements. The process of developing new medicines is increasingly relying on hyperspectral imaging. and thus, hyperspectral imaging will soon be a crucial component of standard operating production for drug production.

Medical hyperspectral imaging has proven to be beneficial in the identification of cancerous cells and also enables clinicians to visualize cancer progression in real time. Doctors can also see the susceptibility or resistance of tumors to various chemotherapy or irradiation therapies. These features have helped in the development of specialized and tailor-made treatments for cancer of the oral cavity, GI tract, and cervix effectively.

Various advantages of hyperspectral imaging in pharmaceutical industries are expected to drive the growth of the global hyperspectral imaging market. Hyperspectral imaging can examine tissue layers way deeper than any other optical imaging techniques available in current biomedical sector. and is therefore considered next-generation imaging and the future of clinical research as well. Increasing application in the field of disease pathogenesis, and live assessment of damage to tissue and organs are also some of the features that can see better usage of hyperspectral imaging devices for medical purposes. There is a growing adoption of medical hyperspectral imaging tools in animal research and industrial application. This is also anticipated to help the growth of global medical hyperspectral imaging devices in long term.

Factor enhancing the growth of medical hyperspectral imaging market:

The hyperspectral medical imaging market is expected to be driven by rising awareness of such tools both in clinicians and patients. In addition to this increased safety, relative ease of use, and advancement of medical imaging capabilities will further enhance the adoption rates of such devices. However, the high investment capital required for such devices and the requirement of high-quality medical infrastructure will hamper the progress of the Global Medical Hyperspectral Imaging Market.

During the projected period, there is expected to be a significant increase in the global market for medical hyperspectral imaging. Some variables that could function as drivers for this market are the expanding uses of HSI in the healthcare industry for diagnostics, image-guided operations, and other therapies along with technical developments. Additionally, the need for hyperspectral imaging technology has increased as a result of the rise in cancer prevalence. Additionally, the increased understanding of disease early detection can help the market to expand.

However, a significant risk of technical failure and a shortage of healthcare infrastructure to support medical hyperspectral imaging can result in difficulties for the growth of the medical hyperspectral imaging market as anticipated. High-quality technicians are required to run such devices as image screening confusion and subpar screening results can occur due to less experienced technicians. The clinical output and cost-effectiveness of hyperspectral imaging may suffer as a result of such complications and thus limit the medical hyperspectral imaging market growth in coming years.

Regional breakdown of market forecast:

During the year 2020, North America accounted for a significant portion of the medical hyperspectral imaging market, and this is expected to maintain its dominance during the forecast period. Due to the presence of well-established healthcare systems in the U.S. and Canada, along with rapidly increasing financial support and investments, expanding industrial uses of hyperspectral imaging, and breakthroughs in hardware and software for image processing and analysis will result in an expansion of this market.  Additionally, throughout the projected period, advancements in healthcare infrastructure and rising consumer desire for accurate surgical operations are also predicted to drive the market for medical hyperspectral imaging in this region. The rest of the world is expected to show moderate growth of the medical hyperspectral imaging devices market.

Key companies involved:

Major players involved in the global hyperspectral imaging market are Brandywine, ClydeHSI, Corning Incorporated, Cubert, CytoViva, Inc, Norsk Elektro Optikk A/S, Orbital Sidekick, Photon Inc., Surface Optics Corp, Ximea Diaspective Vision GmbH, Headwall Photonics Inc., Imec, Resonon Inc., Specim Spectral Imaging Ltd., and Inno-Spec GmbH.

Market Segmentation

By Product

• Hyperspectral Imaging Systems
• Hyperspectral Imaging Accessories

By Application

• Medical Diagnosis
• Tissue and Cell Biology
• Drug Discovery
• Others

By Technology

• Visible Hyperspectral Imaging
• Near-infrared Hyperspectral Imaging
• Ultraviolet Hyperspectral Imaging
• Short-wave Infrared Imaging
• Mid-wave Infrared Hyperspectral Imaging

By End-use

• Diagnostic Centres
• Hospitals
• Research & Academic Centres
• Pharmaceutical & Biotechnology Companies

By Geography

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• South America
  • Brazil
  • Rest of South America